Cannabinoid Medicine Course

Lesson 1 • Cannabinoid Chemistry and Classification

Introduces major and minor cannabinoids, their chemical structures, and biosynthetic pathways. Provides the chemical literacy needed for pharmacology chapters.

Lesson 2 • Cannabis Plant Biology and Taxonomy

Covers species classification, plant anatomy, and cultivation factors affecting cannabinoid content. Grounds all subsequent chemistry in botanical context.

Lesson 3 • Historical and Cultural Medical Use

Traces cannabis use in traditional medicine across cultures and through modern prohibition. Contextualizes current clinical interest within a long therapeutic history.

Lesson 1 • Cannabinoid Receptors and Signaling

Details CB1, CB2, and non-classical receptor distribution and downstream signaling cascades. Explains how receptor activation produces physiological effects.

Lesson 2 • ECS Discovery and Overview

Recounts the scientific discovery of the ECS and its components. Establishes why the ECS is central to understanding cannabinoid medicine.

Lesson 3 • ECS Across Organ Systems

Maps ECS activity in the brain, immune system, gut, and peripheral tissues. Prepares students to connect ECS physiology to specific disease states.

Lesson 1 • Drug Interactions and Contraindications

Identifies clinically significant cannabinoid-drug interactions and patient populations requiring caution. Prepares practitioners to screen patients safely.

Lesson 2 • Pharmacodynamics and Receptor Binding

Analyzes agonist, antagonist, and allosteric modulator activity at cannabinoid receptors. Explains dose-response relationships and therapeutic windows.

Lesson 3 • Synthetic and Pharmaceutical Cannabinoids

Reviews approved pharmaceutical cannabinoid products and synthetic analogs. Distinguishes their pharmacological profiles from plant-derived preparations.

Lesson 4 • Pharmacokinetics of Major Cannabinoids

Examines absorption, distribution, metabolism, and excretion of THC and CBD. Directly informs dosing strategies covered in later chapters.

Lesson 1 • Pain Management with Cannabinoids

Reviews evidence for cannabinoids in neuropathic, inflammatory, and cancer pain. Establishes pain as the most evidence-supported indication for cannabinoid therapy.

Lesson 2 • Gastrointestinal and Inflammatory Conditions

Assesses evidence for IBD, IBS, and systemic inflammatory conditions. Connects ECS gut physiology to clinical outcomes.

Lesson 3 • Oncology and Palliative Care

Covers cannabinoid use for chemotherapy-induced nausea, appetite stimulation, and end-of-life symptom control. Addresses integration with standard oncology protocols.

Lesson 4 • Evaluating Research Quality in Cannabinoid Studies

Teaches critical appraisal of cannabinoid clinical trials, including common methodological limitations. Enables practitioners to distinguish strong from weak evidence.

Lesson 1 • Contraindication and Risk Screening

Identifies absolute and relative contraindications and stratifies patient risk. Ensures practitioners apply a safety-first approach before initiating therapy.

Lesson 2 • Validated Screening and Assessment Tools

Introduces standardized questionnaires for pain, anxiety, sleep, and cannabis use disorder risk. Integrates objective measures into clinical decision-making.

Lesson 3 • Comprehensive Medical History Intake

Outlines the components of a cannabinoid-focused medical history, including prior use and comorbidities. Forms the foundation for individualized treatment planning.

Lesson 1 • Delivery Format and Product Evaluation

Compares oils, capsules, vaporizers, edibles, topicals, and patches for clinical suitability. Teaches practitioners to evaluate product quality and labeling accuracy.

Lesson 2 • THC-to-CBD Ratios and Formulation Choice

Explains how THC:CBD ratios affect therapeutic outcomes and side effect profiles. Guides product selection based on indication and patient tolerance.

Lesson 3 • Pediatric and Geriatric Dosing Adaptations

Modifies standard dosing frameworks for age-related pharmacokinetic differences. Ensures safe and effective therapy in vulnerable age groups.

Lesson 4 • Principles of Cannabinoid Dosing

Establishes start-low, go-slow titration principles and individualized dosing rationale. Directly applies pharmacokinetic knowledge from earlier chapters.

Lesson 1 • Common and Serious Adverse Effects

Catalogs acute and chronic adverse effects of THC and CBD across organ systems. Provides the clinical knowledge base for proactive patient counseling.

Lesson 2 • Cannabis Use Disorder and Dependence

Defines cannabis use disorder, withdrawal syndrome, and dependence risk factors. Equips practitioners to identify and address problematic use patterns.

Lesson 3 • Risk Mitigation and Harm Reduction

Presents structured harm reduction strategies, informed consent practices, and safety monitoring protocols. Translates risk knowledge into actionable clinical procedures.

Lesson 1 • Professional Boundaries and Scope of Practice

Defines scope of practice boundaries and referral obligations for cannabinoid practitioners. Ensures practitioners recognize the limits of their competence.

Lesson 2 • Documentation and Record-Keeping Standards

Establishes best practices for clinical documentation, patient records, and audit readiness. Protects practitioners and patients through thorough record-keeping.

Lesson 3 • Patient Communication and Shared Decision-Making

Develops skills for transparent, evidence-based patient conversations about cannabinoid therapy. Integrates shared decision-making into every stage of care.

Lesson 4 • Ethical Principles in Cannabinoid Practice

Applies bioethical principles of autonomy, beneficence, and justice to cannabinoid prescribing decisions. Addresses conflicts of interest and equitable access.